(CNN/WHDH) --- A monoclonal antibody treatment for Alzheimer's disease called lecanemab slows the progression of cognitive decline by 27% compared with a placebo, drugmakers Biogen…
The Harvord Crimson | Sports
The Harvard Crimson | News
The Boston Hockey Blog
WHDH 7 Boston
The Boston Hockey Blog
The Boston Pilot
The Boston Pilot
